Silexion Therapeutics logo

Silexion Therapeutics Share Price (NASDAQ: SLXN)

$7.32

-0.42

(-5.43%)

Last updated on

Check the interactive Silexion Therapeutics Stock chart to analyse performance

Silexion Therapeutics stock performance

as on August 30, 2025 at 1:27 am IST

  • Today's Low:$7.26
    Today's High:$7.72

    Day's Volatility :5.96%

  • 52 Weeks Low:$6.51
    52 Weeks High:$216.00

    52 Weeks Volatility :96.99%

Silexion Therapeutics Stock Returns

PeriodSilexion Therapeutics CorpIndex (Russel 2000)
3 Months
-49.58%
0.0%
6 Months
-53.9%
0.0%
1 Year
-95.11%
0.0%
3 Years
-97.24%
-4.1%

Silexion Therapeutics Corp Key Stats

Check Silexion Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$7.74
Open
$7.72
Today's High
$7.72
Today's Low
$7.26
Market Capitalization
$5.7M
Today's Volume
$19.0K
52 Week High
$216.0
52 Week Low
$6.51
Revenue TTM
$0.0
EBITDA
$-12.5M
Earnings Per Share (EPS)
$-30.78
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-116.66%

Stock Returns calculator for Silexion Therapeutics Stock including INR - Dollar returns

The Silexion Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Silexion Therapeutics investment value today

Current value as on today

₹10,213

Returns

₹89,787

(-89.79%)

Returns from Silexion Therapeutics Stock

₹95,071 (-95.07%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Silexion Therapeutics Stock

-4%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Silexion Therapeutics Stock from India on INDmoney has decreased by -4% in the last 30 days, reflecting a downward trend in search activity.

Analyst Recommendation on Silexion Therapeutics Stock

Rating
Trend

Silexion Therapeutics Share Price Target

What analysts predicted

Upside of 227.87%

Target:

$24.00

Current:

$7.32

Silexion Therapeutics share price target is $24.00, a slight Upside of 227.87% compared to current price of $7.32 as per analysts' prediction.

Silexion Therapeutics Stock Insights

  • Price Movement

    In the last 1 month, SLXN stock has moved down by -51.4%
  • SLXN vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 166.2%

Silexion Therapeutics Technicals Summary

Sell

Neutral

Buy

Silexion Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Silexion Therapeutics Corp Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Silexion Therapeutics Corp logo
-21.77%
-53.9%
-95.11%
-97.24%
-97.24%
Regeneron Pharmaceuticals, Inc. logo
3.92%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
2.49%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-15.42%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
11.08%
83.28%
75.87%
111.28%
242.25%

About Silexion Therapeutics Corp

Silexion Therapeutics Corp, a biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors. The company engages in the treatment of solid tumors through its proprietary LODER delivery platform. Its products comprise SiG12D-LODER that has completed pre-clinical studies and an open label Phase I clinical trial for the treatment of pancreatic cancer; Prostate-LODER, which is in pre-clinical studies for the treatment of prostate cancer; and GBM-LODER that is in pre-clinical studies to target Glioblastoma Multiform, a malignant primary brain tumor. Silexion Therapeutics Corp has collaboration with Evonik Corporation for the development of an advanced siRNA formulation to enhance cancer treatment. The company was founded in 2008 and is headquartered in Jerusalem, Israel.
Organization
Silexion Therapeutics
Employees
11
CEO
Mr. Ilan Hadar M.B.A.
Industry
Miscellaneous

Key Management of Silexion Therapeutics Corp

NameTitle
Mr. Ilan Hadar M.B.A.
Chairman & CEO
Ms. Mirit Horenshtein Hadar
EVP of Finance Affairs, CFO & Secretary
Dr. Mitchell Shirvan M.B.A., Ph.D.
Chief Scientific & Development Officer

Important FAQs about investing in SLXN Stock from India :

What is Silexion Therapeutics share price today?

Silexion Therapeutics share price today is $7.32 as on at the close of the market. Silexion Therapeutics share today touched a day high of $7.72 and a low of $7.26.

What is the 52 week high and 52 week low for Silexion Therapeutics share?

Silexion Therapeutics share touched a 52 week high of $216.00 and a 52 week low of $6.51. Silexion Therapeutics stock price today i.e. is closed at $7.32, lower by 96.61% versus the 52 week high.

How to invest in Silexion Therapeutics Stock (SLXN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Silexion Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Silexion Therapeutics Shares that will get you 0.2049 shares as per Silexion Therapeutics share price of $7.32 per share as on August 30, 2025 at 1:27 am IST.

What is the minimum amount required to buy Silexion Therapeutics Stock (SLXN) from India?

Indian investors can start investing in Silexion Therapeutics (SLXN) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Silexion Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Silexion Therapeutics share’s latest price of $7.32 as on August 30, 2025 at 1:27 am IST, you will get 1.3661 shares of Silexion Therapeutics. Learn more about fractional shares .

What are the returns that Silexion Therapeutics has given to Indian investors in the last 5 years?

Silexion Therapeutics stock has given -97.24% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?